Alterations in immune function with biologic therapies for autoimmune disease

Area of Science:

• Immunology
• Rheumatology
• Gastroenterology
• Dermatology

Background:

• Autoimmune disorders involve immune system dysregulation.
• Biologic agents offer improved treatment for inflammatory autoimmune diseases.
• Biologics target key immune pathways, improving patient outcomes.

Purpose of the Study:

• To review clinical evidence of adverse effects from biologic agents.
• To discuss the immunologic mechanisms underlying these adverse effects.
• To provide a comprehensive overview of biologic-associated risks.

Main Methods:

• Literature review of clinical studies on biologic agents.
• Analysis of immunologic mechanisms of adverse events.
• Synthesis of current evidence on immunosuppression and autoimmunity.

Main Results:

• Biologic agents can lead to immunosuppression, increasing infection risk.
• Paradoxical inflammation or new autoimmune conditions can occur.
• Adverse effects vary depending on the specific biologic agent and target.

Conclusions:

• Biologic therapies, while effective, carry potential risks.
• Understanding mechanisms of adverse effects is crucial for patient safety.
• Careful monitoring and risk-benefit assessment are essential for biologic use.